Patent ID: 11857617
Assignee: TOPELIA AUST LIMITED (652 771 670)
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 12:
13. The method of claim 1, wherein the
(i) 1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, or a compound having the following structure and molecular weight:, (ii) ritonavir, and
(iii) a drug combination comprising
(1) ivermectin,
(2) doxycycline, and
(3) zinc,

are formulated together, or separately, or are formulated together or separately in or as a liquid, or are administered as a drink or in drops, or are administered as nasal drops or in a mist, a tablet, a capsule, a gel, a geltab, a powder, a lozenge, an aerosol or spray.